Cargando…

A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria

BACKGROUND: Gram-positive bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA) and enterococci, have shown a remarkable ability to develop resistance to antimicrobial agents. OBJECTIVE: We aimed to assess possible enhancement of the antimicrobial activity of vancomycin, amoxicilli...

Descripción completa

Detalles Bibliográficos
Autores principales: Sallam, Mariam Madkour, Abou-Aisha, Khaled, El-Azizi, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153292/
https://www.ncbi.nlm.nih.gov/pubmed/27994476
http://dx.doi.org/10.2147/IDR.S120227
_version_ 1782474668126502912
author Sallam, Mariam Madkour
Abou-Aisha, Khaled
El-Azizi, Mohamed
author_facet Sallam, Mariam Madkour
Abou-Aisha, Khaled
El-Azizi, Mohamed
author_sort Sallam, Mariam Madkour
collection PubMed
description BACKGROUND: Gram-positive bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA) and enterococci, have shown a remarkable ability to develop resistance to antimicrobial agents. OBJECTIVE: We aimed to assess possible enhancement of the antimicrobial activity of vancomycin, amoxicillin, clarithromycin, and azithromycin by human polyclonal intravenous immunoglobulin G (IVIG) against 34 multidrug-resistant (MDR) bacterial isolates, including MRSA, Enterococcus faecium, and Enterococcus faecalis. MATERIALS AND METHODS: Double combinations of the antibiotics with the IVIG were assessed by checkerboard assay, where the interaction was evaluated with respect to the minimum inhibitory concentration (MIC) of the antibiotics. The results of the checkerboard assay were verified in vitro using time-kill assay and in vivo using an invasive sepsis murine model. RESULTS: The checkerboard assay showed that IVIG enhanced the antimicrobial activity of amoxicillin and clarithromycin against isolates from the three groups of bacteria, which were resistant to the same antibiotics when tested in the absence of IVIG. The efficacy of vancomycin against 15% of the tested isolates was enhanced when it was combined with the antibodies. Antagonism was demonstrated in 47% of the E. faecalis isolates when clarithromycin was combined with the IVIG. Synergism was proved in the time-kill assay when amoxicillin was combined with the antibodies; meanwhile, antagonism was not demonstrated in all tested combinations, even in combinations that showed such response in checkerboard assay. CONCLUSION: The suggested approach is promising and could be helpful to enhance the antimicrobial activity of not only effective antibiotics but also antibiotics that have been proven to be ineffective against MDR bacteria. To our knowledge, this combinatorial approach against MDR bacteria, such as MRSA and enterococci, has not been investigated before.
format Online
Article
Text
id pubmed-5153292
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-51532922016-12-19 A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria Sallam, Mariam Madkour Abou-Aisha, Khaled El-Azizi, Mohamed Infect Drug Resist Original Research BACKGROUND: Gram-positive bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA) and enterococci, have shown a remarkable ability to develop resistance to antimicrobial agents. OBJECTIVE: We aimed to assess possible enhancement of the antimicrobial activity of vancomycin, amoxicillin, clarithromycin, and azithromycin by human polyclonal intravenous immunoglobulin G (IVIG) against 34 multidrug-resistant (MDR) bacterial isolates, including MRSA, Enterococcus faecium, and Enterococcus faecalis. MATERIALS AND METHODS: Double combinations of the antibiotics with the IVIG were assessed by checkerboard assay, where the interaction was evaluated with respect to the minimum inhibitory concentration (MIC) of the antibiotics. The results of the checkerboard assay were verified in vitro using time-kill assay and in vivo using an invasive sepsis murine model. RESULTS: The checkerboard assay showed that IVIG enhanced the antimicrobial activity of amoxicillin and clarithromycin against isolates from the three groups of bacteria, which were resistant to the same antibiotics when tested in the absence of IVIG. The efficacy of vancomycin against 15% of the tested isolates was enhanced when it was combined with the antibodies. Antagonism was demonstrated in 47% of the E. faecalis isolates when clarithromycin was combined with the IVIG. Synergism was proved in the time-kill assay when amoxicillin was combined with the antibodies; meanwhile, antagonism was not demonstrated in all tested combinations, even in combinations that showed such response in checkerboard assay. CONCLUSION: The suggested approach is promising and could be helpful to enhance the antimicrobial activity of not only effective antibiotics but also antibiotics that have been proven to be ineffective against MDR bacteria. To our knowledge, this combinatorial approach against MDR bacteria, such as MRSA and enterococci, has not been investigated before. Dove Medical Press 2016-12-08 /pmc/articles/PMC5153292/ /pubmed/27994476 http://dx.doi.org/10.2147/IDR.S120227 Text en © 2016 Sallam et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Sallam, Mariam Madkour
Abou-Aisha, Khaled
El-Azizi, Mohamed
A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria
title A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria
title_full A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria
title_fullStr A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria
title_full_unstemmed A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria
title_short A novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteria
title_sort novel combination approach of human polyclonal ivig and antibiotics against multidrug-resistant gram-positive bacteria
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153292/
https://www.ncbi.nlm.nih.gov/pubmed/27994476
http://dx.doi.org/10.2147/IDR.S120227
work_keys_str_mv AT sallammariammadkour anovelcombinationapproachofhumanpolyclonalivigandantibioticsagainstmultidrugresistantgrampositivebacteria
AT abouaishakhaled anovelcombinationapproachofhumanpolyclonalivigandantibioticsagainstmultidrugresistantgrampositivebacteria
AT elazizimohamed anovelcombinationapproachofhumanpolyclonalivigandantibioticsagainstmultidrugresistantgrampositivebacteria
AT sallammariammadkour novelcombinationapproachofhumanpolyclonalivigandantibioticsagainstmultidrugresistantgrampositivebacteria
AT abouaishakhaled novelcombinationapproachofhumanpolyclonalivigandantibioticsagainstmultidrugresistantgrampositivebacteria
AT elazizimohamed novelcombinationapproachofhumanpolyclonalivigandantibioticsagainstmultidrugresistantgrampositivebacteria